Skip to content
Invivoscribe logo — Improving Lives with Precision Diagnostics®

Invivoscribe

Improving Lives with Precision Diagnostics®

Founded 1995 United States San Diego, United States 199 employees Biotechnology, Health Care

General Information

Company Name Invivoscribe
Founded Year 1995
Location United States San Diego, United States
Employees 199
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Invivoscribe. To contact Invivoscribe, visit invivoscribe.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Invivoscribe compare?

A PDF of Invivoscribe and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Invivoscribe soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Invivoscribe

Invivoscribe® is a global leader in the biotechnology and healthcare industries, founded in 1995 with its headquarters in the United States. The company is dedicated to Improving Lives with Precision Diagnostics® and focuses on advancing the quality of healthcare through its innovative products and clinical services for oncology. Invivoscribe® operates with a streamlined CDx® (companion diagnostic) model, which accelerates the development of novel therapeutics, enabling personalized approaches to patient care. The company offers a comprehensive range of platform-agnostic assays, reagents, controls, and software for clonal gene rearrangements, translocations, gene mutation testing, and measurable residual disease (MRD). Through its subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM®), Invivoscribe® provides extensive clinical diagnostic and biopharma services for the detection and monitoring of myelo- and lymphoproliferative disorders. The LabPMM network performs globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations, catering to patient care in the U.S., Europe, and Asia. Invivoscribe® consistently surpasses industry and regulatory standards, playing a crucial role in identifying, stratifying, and monitoring hematologic cancers, thereby enabling scientific advancements and empowering clinicians to make informed treatment decisions. The company is dedicated to revolutionizing oncology diagnostics and improving patient outcomes worldwide. In summary, Invivoscribe® has established itself as a key player in precision medicine, offering a wide range of innovative products and services that are vital for the advancement of oncology diagnostics and patient care.

Business keywords: precision diagnostics, oncology, companion diagnostics, therapeutics, cGMP facility, clonal gene rearrangements, gene mutation testing, measurable residual disease, molecular testing, precision medicine, biopharma services, clinical diagnostics, flow cytometry, global healthcare

No funding data available for Invivoscribe yet.

Invivoscribe Alternatives & Competitors

View All Alternatives
Invivoscribe vs
Predicine
Predicine United States

Advancing precision medicine through next-generation liquid biopsy oncology platform

89 employees
Biotechnology, Health Care
Invivoscribe vs

Companion Diagnostics for Precision Medicine in Oncology

Seed
3 employees
Biotechnology, Health Care
Invivoscribe vs
Biocartis
Biocartis Belgium

High precision diagnostics for personalized medicine

Grant
314 employees
Biotechnology, Health Care

FAQ About Invivoscribe

Improving Lives with Precision Diagnostics®
Invivoscribe was founded in 1995.
Invivoscribe is headquartered in San Diego, United States.
Invivoscribe operates in Biotechnology and Health Care. Its work centres on precision diagnostics, oncology, companion diagnostics and therapeutics.
Invivoscribe has approximately 199 employees.
Top alternatives and competitors to Invivoscribe include Predicine, CY Molecular Diagnostics (CYMD), Biocartis, Empire Genomics, Geneseeq Technology Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Invivoscribe and Predicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Invivoscribe, https://bouncewatch.com/company/invivoscribe, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout